Medical Science Liaison Emerging Therapies MAEG, International

Medical Science Liaison Emerging Therapies MAEG, International

argenx

Remote, Belgium

PURPOSE OF THE FUNCTION

The Medical Science Liaison Emerging Therapies, INTERNATIONAL Medical Affairs and Evidence Generation team will focus on communicating clinical data and providing scientific expertise, about argenx investigational products, and compounds in development, in a strictly scientific, non-promotional manner, and in full compliance with argenx policies and procedures. MSL Emerging Therapies serves to enhance the scientific credibility of the Company with key scientific institutions by supporting scientific dialogue and collaborations in the areas of research, medical and scientific exchange, including facilitation of requests for scientific and medical information.

ROLES AND RESPONSIBILITIES

• This MSL role will cover the Netherlands and Belgium, with regular face-to-face meetings with KOLs in these countries. It will also include mainly virtual engagements with stakeholders in Canada, Australia, and the Middle East - primarily in the UAE and Saudi Arabia;
• Act as a subject matter expert for pipeline products in preclinical and early-phase clinical stages and be acknowledged internally and externally as an expert. Be an expert presenter, facilitator at advisory boards, expert meetings etc.;
• Identify potential high-impact medical research projects and publication opportunities (e.g., white papers to inform treatment guidelines), in line with argenx identified areas of interest to support enterprise objectives;
• Identification of disease specific KOLs/HCPs to build a cross specialty KOL map for future indications to lay a foundation for successful launches;
• Develop and maintain relationships with KOLs to collaborate on research projects, advisory boards and peer-to-peer educational initiatives​;
• Responsible for the supervision of experts and centres in a number of European countries to be defined;
• Ensure timely and informative scientific/medical exchange and education for HCPs on topics like disease awareness, diagnostics, treatment and adherence that accurately reflects scientific data and research objectives, compliantly and in line with the medical strategy;​
• Act as a key resource for scientific and clinical questions related to pipeline development and product lifecycle. Respond to questions from the healthcare community with integrity, compliance, and adherence to all legal, regulatory, and argenx guidelines, policies & procedure​;
• Provide KOLs with the latest clinical data and emerging scientific trends relevant to the pipeline, facilitating meaningful scientific discussions;
• Initiate and support high impact medical activities, such as advisory boards, congress symposia, hospital meetings, speaker development programs and reimbursement agency education;
• Lead or participate in the training and education of internal teams on therapeutic areas, pipeline assets, and scientific advancements;
• Communicate key clinical and scientific findings from ongoing trials to relevant stakeholders, ensuring that the information is understood and accurately represented;
• Collaborate and provide input in the creation of medical strategies for pre-launch and early-stage pipeline products by staying informed about industry trends, competitive landscapes, and scientific developments in relevant therapeutic areas;
• Attend appropriate international congresses and meetings to gather intelligence, assist personal education, ensuring these opportunities are utilized to develop relationships with important customers;
• Ensure medical accuracy of Medical Affairs activities, including advisory boards and scientific expert meetings, publications, scientific congress activities, medical education, medical information content and medical field programs;
• Ensure all medical affairs activities maintain the highest standards, comply with applicable pharmaceutical regulation, as well as argenx policies and procedures.

SKILLS AND COMPETENCIES

• Ability to develop and maintain a high level of knowledge in complex disease areas;
• Good understanding of clinical trials and execution;
• Demonstrated ability to build relationships and collaborate productively with external stakeholders (e.g., medical experts, healthcare professionals);​
• Scientific and customer-centric mindset with successful track record of delivering results that meet or exceed targeted objectives;
• Able to problem solve proactively and translate territory / organizational needs into action;​
• Can operate with significant autonomy to assess priorities and customize decisions in real time;
• Ability to work collaboratively and effectively together within cross-functional teams and networks;
• Demonstrated communication skills, within a multi-cultural and multi-lingual global environment;
• Is agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilience;
• Derives energy from operating in a dynamic, complex, fast-moving, and frequently changing business environment;
• Demonstrable experience with project management, proactive planning, priority setting, and securing alignment;
• Drives toward outcomes;
• Ambitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop. This includes being comfortable giving and receiving feedback in a diverse environment;
• Passionate and prepared to lead and contribute to our culture, which is driven by our corporate values of co-creation, innovation, empowerment, excellence, and humility.

EDUCATION, EXPERIENCE

• Medical, pharmaceutical or high-level scientific degree (MD, PharmD, PhD);
• Minimum of 8+ years field-based experience in biopharmaceutical industry;
• Proven experience in Medical Affairs, including a hands-on medical field role, is mandatory;
• Therapeutic area experience in neurology, rheumatology, dermatology, immunology, nephrology and/or other rare diseases is an advantage​;
• Experience in clinical R&D is beneficial​;
• Strong understanding of compliance, legal and regulatory landscape related to interactions with healthcare professionals​;
• Business fluency in English and at least one other major European language;
• Arabic language skills would be considered a strong asset for virtual interactions in the Middle East (UAE and Saudi Arabia).